Literature DB >> 10926900

Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection.

D W Holt1, T Lee, K Jones, A Johnston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10926900

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  10 in total

1.  Protease inhibitors and diltiazem increase tacrolimus blood concentration in a patient with renal transplantation: a case report.

Authors:  Gaëlle Hardy; Françoise Stanke-Labesque; Claudine Contamin; Françoise Serre-Debeauvais; François Bayle; Philippe Zaoui; Germain Bessard
Journal:  Eur J Clin Pharmacol       Date:  2004-09-15       Impact factor: 2.953

2.  Methodological Considerations for Hair Cortisol Measurements in Children.

Authors:  Radomir Slominski; Cynthia R Rovnaghi; Kanwaljeet J S Anand
Journal:  Ther Drug Monit       Date:  2015-12       Impact factor: 3.681

3.  Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.

Authors:  Nassim Djebli; Annick Rousseau; Guillaume Hoizey; Jean-Philippe Rerolle; Olivier Toupance; Yann Le Meur; Pierre Marquet
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 4.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  A comprehensive review of immunosuppression used for liver transplantation.

Authors:  Sandeep Mukherjee; Urmila Mukherjee
Journal:  J Transplant       Date:  2009-07-16

6.  Stability issues of mycophenolic Acid in plasma: from patient to laboratory.

Authors:  B S Mathew; G T John; S J Chandy; D H Fleming
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

7.  Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.

Authors:  Rakesh K Goyal; Kelong Han; Donna A Wall; Michael A Pulsipher; Nancy Bunin; Stephan A Grupp; Sripal R Mada; Raman Venkataramanan
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-21       Impact factor: 5.742

8.  Adenosine triphosphate-competitive mTOR inhibitors: a new class of immunosuppressive agents that inhibit allograft rejection.

Authors:  B R Rosborough; D Raïch-Regué; Q Liu; R Venkataramanan; H R Turnquist; A W Thomson
Journal:  Am J Transplant       Date:  2014-08-04       Impact factor: 8.086

9.  A review on therapeutic drug monitoring of immunosuppressant drugs.

Authors:  Niloufar Mohammadpour; Sepideh Elyasi; Naser Vahdati; Amir Hooshang Mohammadpour; Jamal Shamsara
Journal:  Iran J Basic Med Sci       Date:  2011-11       Impact factor: 2.699

10.  Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients.

Authors:  Magdalena Bodnar-Broniarczyk; Karola Warzyszyńska; Katarzyna Czerwińska; Dorota Marszałek; Natalia Dziewa; Maciej Kosieradzki; Tomasz Pawiński
Journal:  Pharmaceutics       Date:  2022-03-12       Impact factor: 6.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.